Related references
Note: Only part of the references are listed.Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Michael H. Meel et al.
CLINICAL CANCER RESEARCH (2020)
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
Camilla Calandrini et al.
NATURE COMMUNICATIONS (2020)
Organoid Models of Tumor Immunology
Kanako Yuki et al.
TRENDS IN IMMUNOLOGY (2020)
Organoids in immunological research
Yotam E. Bar-Ephraim et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
P. Fusco et al.
BMC CANCER (2019)
Immunotherapy in Pediatric Solid Tumors-A Systematic Review
Raoud Marayati et al.
CANCERS (2019)
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Diana Carvalho et al.
COMMUNICATIONS BIOLOGY (2019)
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Mara Vinci et al.
NATURE MEDICINE (2018)
An efficient method for the transduction of primary pediatric glioma neurospheres
Michael H. Meel et al.
METHODSX (2018)
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma
A. Charlotte P. Sewing et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2017)
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Faizaan Mohammad et al.
NATURE MEDICINE (2017)
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Jason Lohmueller et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors
Cheng Xu et al.
ONCOTARGET (2017)
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
Tammy Hennika et al.
PLOS ONE (2017)
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
J. V. Cockle et al.
BRITISH JOURNAL OF CANCER (2015)
Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression
Simone Krinner et al.
HUMAN GENE THERAPY (2015)
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours
Laurel T. Bate-Eya et al.
EUROPEAN JOURNAL OF CANCER (2014)
Co-culture systems and technologies: taking synthetic biology to the next level
Lisa Goers et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma
Ning Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay
Mobin A. Karimi et al.
PLOS ONE (2014)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function
Lixian Dong et al.
GLYCOCONJUGATE JOURNAL (2011)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death
J Wesierska-Gadek et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Share Paper
